Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
Int J Radiat Oncol Biol Phys. 2018 Mar 15;100(4):1004-1015. doi: 10.1016/j.ijrobp.2017.12.262. Epub 2017 Dec 21.
Soft tissue sarcomas (STS) are rare malignancies that require complex multidisciplinary management. Therefore, facilities with high sarcoma case volume may demonstrate superior outcomes. We hypothesized that STS treatment at high-volume (HV) facilities would be associated with improved overall survival (OS).
Patients aged ≥18 years with nonmetastatic STS treated with surgery and radiation therapy at a single facility from 2004 through 2013 were identified from the National Cancer Database. Facilities were dichotomized into HV and low-volume (LV) cohorts based on total case volume over the study period. OS was assessed using multivariable Cox regression with propensity score-matching. Patterns of care were assessed using multivariable logistic regression analysis.
Of 9025 total patients, 1578 (17%) and 7447 (83%) were treated at HV and LV facilities, respectively. On multivariable analysis, high educational attainment, larger tumor size, higher grade, and negative surgical margins were statistically significantly associated with treatment at HV facilities; conversely, black race and non-metropolitan residence were negative predictors of treatment at HV facilities. On propensity score-matched multivariable analysis, treatment at HV facilities versus LV facilities was associated with improved OS (hazard ratio, 0.87, 95% confidence interval, 0.80-0.95; P = .001). Older age, lack of insurance, greater comorbidity, larger tumor size, higher tumor grade, and positive surgical margins were associated with statistically significantly worse OS.
In this observational cohort study using the National Cancer Database, receipt of surgery and radiation therapy at HV facilities was associated with improved OS in patients with STS. Potential sociodemographic disparities limit access to care at HV facilities for certain populations. Our findings highlight the importance of receipt of care at HV facilities for patients with STS and warrant further study into improving access to care at HV facilities.
软组织肉瘤(STS)是一种罕见的恶性肿瘤,需要进行复杂的多学科管理。因此,具有高肉瘤病例量的机构可能会显示出更好的结果。我们假设在高容量(HV)机构治疗 STS 与改善总体生存率(OS)相关。
从国家癌症数据库中确定了 2004 年至 2013 年期间在单一机构接受手术和放疗治疗的年龄≥18 岁的非转移性 STS 患者。根据研究期间的总病例量,将机构分为高容量(HV)和低容量(LV)队列。使用多变量 Cox 回归和倾向评分匹配评估 OS。使用多变量逻辑回归分析评估护理模式。
在 9025 名总患者中,1578 名(17%)和 7447 名(83%)分别在 HV 和 LV 机构接受治疗。多变量分析显示,较高的教育程度、较大的肿瘤大小、较高的分级和阴性手术切缘与 HV 机构治疗显著相关;相反,黑人和非城市居民是 HV 机构治疗的负面预测因素。在倾向评分匹配的多变量分析中,与 LV 机构相比,在 HV 机构治疗与改善 OS 相关(风险比,0.87,95%置信区间,0.80-0.95;P=0.001)。年龄较大、缺乏保险、合并症较多、肿瘤较大、肿瘤分级较高和阳性手术切缘与 OS 显著较差相关。
在这项使用国家癌症数据库的观察性队列研究中,在 HV 机构接受手术和放疗与 STS 患者的 OS 改善相关。潜在的社会人口统计学差异限制了某些人群在 HV 机构获得治疗的机会。我们的研究结果强调了 STS 患者在 HV 机构接受治疗的重要性,并需要进一步研究如何改善 HV 机构的治疗机会。